Print

Print


ESSENTIAL TREMOR        30 June 2000                Page 1 of 2
Neurology 2000; Volume 54, Supplement 4, Pages 1-45:

Feeling that scientific knowledge about essential tremor is
unduly sparse and its study neglected, a group of prominent
experts decided to write down all they know about it at present,
which is summarized in articles comprising Supplement 4 of
the journal Neurology for this year, as follows (titles edited):
Deuschl G, Koller W   Introduction                             1
Elble R               Diagnostic Criteria                      2
Bain P et al          Diagnostic Criteria                      7
Findley L             Epidemiology                             8
Deuschl G, Elble R    Pathophysiology                         14
Jankovic J            Clinical Characteristics                21
Bain P                Tremor Measurement and Quality of Life  26
Koller W et al        Pharmacological Treatment               30
Pahwa R et al         Surgical Treatment                      39
(not listed)          Support Organizations                   45

Since Supplement 4 is printed as a stand-alone booklet, I shall
try to offer highlights of the document as a whole, rather than
review each contribution separately. Much of the information has
been published by these authors before, but many interesting bits
and pieces are new to me. Owing to the current state of knowledge
about ET, the various authors here don't necessarily agree.

Essential Tremor (ET) is known as an involuntary oscillation
involving skeletal muscles, nearly always of arms or hands,
and less often the head, legs, face, voice, or trunk. The
frequency is taken to be in the range 4-12Hz, possibly related
somewhat to the patient's age. For purposes of study and
diagnosis, several kinds of tremor are defined, such as
resting, postural, kinetic, isometric, and action tremors.
For ET research, something called harmaline is found to induce
similar tremor in animals, and in animals the part of the brain
affected by harmaline is the inferior olive. From this, workers
infer that ET in humans may be an oscillation of the olivo-
cerebellar-thalamo-cortical loop. Another discovery from
neurophysiological studies, that should be useful in diagnosis,
is that the waveform (time history) of tremor motion in PD is
distinctly different from that of ET and other tremors. But, ET
may on occasion occur together with PD.

Essential Tremor (ET) may afflict up to 5% of people over 40.
Genetic origin has long been suspected, simply because no
plausible environmental cause is known. There are instances of
familial clusters, but most cases seem to be sporadic. Recently,
though, the first genes related to ET have been found. Probably
there are many, leading to many variations in the disorder. The
articles here hardly address such questions as onset age or rate
of progression.

ESSENTIAL TREMOR                                 Page 2 of 2

Diagnosis is difficult, partly because the medical community is
just now reaching detailed agreement on a definition of ET. ET
seems to be an uncontrolled oscillation in the signal network of
the central nervous system, likely involving the cerebellum. The
range of symptom severity is wide, disabling enough in some to
cause retirement from work, but many of those who fit the current
definition of ET don't seek medical attention.

Proposed criteria for diagnosis of ET are based largely on
exclusion of other disorders. For example if the tremor is
accompanied by rigidity, bradykinesia, or gait disturbance,
or if it is unilateral, the diagnosis would lean toward PD.

The most popular drugs for ET are "beta-blockers" such as
propranolol (Inderal) or the anticonvulsant agent primidone
(Mysoline), although many others are being tried. Alcohol also
is effective, but the mechanism of action is unknown.

As with PD, stereotactic surgery, utilizing either lesioning or
chronic stimulation (DBS), is effective against ET, but usually
reserved for cases where drug therapy has failed. The current
site of choice is the ventral intermediate nucleus (VIM) of the
thalamus. Bilateral thalamotomy is usually avoided, due to high
risk of adverse effects, but bilateral DBS of the same site
seems to be safe.


--
J. R. Bruman   (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013